Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorKutlu, Ömer
dc.contributor.authorDemircan, Yuhanize Taş
dc.contributor.authorYıldız, Kenan
dc.contributor.authorKalkan, Gӧknur
dc.contributor.authorDemirseren, Duriye Deniz
dc.contributor.authorAn, İsa
dc.contributor.authorOba, Muazzez Çiğdem
dc.contributor.authorKılıç, Fatma Arzu
dc.date.accessioned2023-07-20T10:37:54Z
dc.date.available2023-07-20T10:37:54Z
dc.date.issued2022en_US
dc.identifier.issn0011-9059 / 1365-4632
dc.identifier.urihttps://doi.org/10.1111/ijd.16454
dc.identifier.urihttps://hdl.handle.net/20.500.12462/13237
dc.descriptionKılıç, Fatma Arzu (Balikesir Author)en_US
dc.description.abstractBackground A broad spectrum of skin diseases, including hair and nails, can be directly or indirectly triggered by COVID-19. It is aimed to examine the type and frequency of hair and nail disorders after COVID-19 infection. Methods This is a multicenter study conducted on consecutive 2171 post-COVID-19 patients. Patients who developed hair and nail disorders and did not develop hair and nail disorders were recruited as subject and control groups. The type and frequency of hair and nail disorders were examined. Results The rate of the previous admission in hospital due to COVID-19 was statistically significantly more common in patients who developed hair loss after getting infected with COVID-19 (P < 0.001). Telogen effluvium (85%) was the most common hair loss type followed by worsening of androgenetic alopecia (7%) after COVID-19 infection. The mean stress scores during and after getting infected with COVID-19 were 6.88 +/- 2.77 and 3.64 +/- 3.04, respectively, in the hair loss group and were 5.77 +/- 3.18 and 2.81 +/- 2.84, respectively, in the control group (P < 0.001, P < 0.001). The frequency of recurrent COVID-19 was statistically significantly higher in men with severe androgenetic alopecia (Grades 4-7 HNS) (P = 0.012; Odds ratio: 2.931 [1.222-7.027]). The most common nail disorders were leukonychia, onycholysis, Beau's lines, onychomadesis, and onychoschisis, respectively. The symptoms of COVID-19 were statistically significantly more common in patients having nail disorders after getting infected with COVID-19 when compared to the control group (P < 0.05). Conclusion The development of both nail and hair disorders after COVID-19 seems to be related to a history of severe COVID-19.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.relation.isversionof10.1111/ijd.16454en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectTelogen Effluviumen_US
dc.subjectTMPRSS2en_US
dc.subjectStressen_US
dc.subjectLinesen_US
dc.subjectTrichodyniaen_US
dc.subjectACE2en_US
dc.subjectCovid-19en_US
dc.titleThe effect of COVID-19 on development of hair and nail disorders: a Turkish multicenter, controlled studyen_US
dc.typearticleen_US
dc.relation.journalInternational Journal of Dermatologyen_US
dc.contributor.departmentTıp Fakültesien_US
dc.identifier.volume62en_US
dc.identifier.issue2en_US
dc.identifier.startpage202en_US
dc.identifier.endpage211en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster